Abstract
A single point mutation (Phe340-->Leu340) of a conserved phenylalanine abolishes 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]mesulergine but not [3H]ketanserin binding to 5-hydroxytryptamine2 receptors.
M S Choudhary, S Craigo and B L Roth
Molecular Pharmacology May 1993, 43 (5) 755-761;